Contract Research & Development
Total Trials
24
As Lead Sponsor
7
As Collaborator
17
Total Enrollment
49,052
NCT00782197
Autologous Plasma Rich in Growth Factors (PRGF) Treating the Symptomatic Knee OA
Phase: Phase 4
Role: Lead Sponsor
Start: Jan 31, 2008
Completion: Not specified
NCT04635514
Lateral Vaginal Wall Site-specific Defect Reconstructions
Phase: N/A
Start: Nov 15, 2012
Completion: Nov 7, 2019
NCT01771302
Efficiency of PRGF-Endoret in Combination With a Bone Graft in Lateral Sinus Floor Elevation
Role: Collaborator
Start: Jan 31, 2013
Completion: Apr 30, 2014
NCT01885676
Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia
Start: Sep 16, 2013
Completion: Dec 18, 2017
NCT02326194
A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults.
Phase: Phase 1
Start: Dec 31, 2014
Completion: Jul 31, 2015
NCT02533791
A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization
Start: Jul 31, 2015
Completion: Oct 31, 2015
NCT03415633
Validity of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea
Start: Sep 30, 2015
Completion: Sep 30, 2018
NCT02575456
A Clinical Trial to Evaluate the Recombinant Human Type5 Adenovirus Vector Based Ebola Virus Disease Vaccine
Phase: Phase 2
Start: Oct 31, 2015
Completion: Jul 31, 2016
NCT02795013
Genetic Study of Families With High Frequency of Hodgkin Lymphoma
Start: Aug 17, 2016
Completion: Feb 27, 2018
NCT02707120
Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis
Start: Jan 4, 2018
Completion: Jan 31, 2020
NCT03943680
Plasma Rich in Growth Factors in Post-extraction Sockets
Start: Mar 4, 2019
Completion: Jul 31, 2025
NCT03842995
South-seq: Deoxyribonucleic Acid (DNA) Sequencing for Newborn Nurseries in the South
Start: Apr 15, 2019
Completion: Dec 31, 2023
NCT04904692
Virological and Immunological Monitoring in Patients (suspected Of/confirmed With) COVID-19
Start: Mar 23, 2020
Completion: Sep 30, 2024
NCT04398147
Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada
Phase: Phase 1/2
Start: Aug 1, 2020
Completion: Dec 30, 2021
NCT04543292
Clinical Evaluation of Polytetrafluoroethylene (PTFE, MATFILL) for the Sealing of Prosthetic Chimneys.
Start: Sep 1, 2020
Completion: Nov 6, 2020
NCT04526990
Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above
Phase: Phase 3
Start: Sep 15, 2020
Completion: Oct 21, 2022
NCT04566770
A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
Start: Sep 24, 2020
Completion: Jan 19, 2022
NCT04840992
Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation
Start: Apr 21, 2021
Completion: Aug 9, 2022
NCT05124561
Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)
Start: Dec 15, 2021
Completion: Aug 20, 2022
NCT05169008
A Study to Evaluate the Safety and Immunogenicity of Ad5-nCoV and Ad5-nCoV-IH in CoronaVac Immunized Children and Adolescents
Start: Feb 25, 2022
Completion: Jan 13, 2023
NCT05161169
Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants
Start: Dec 21, 2022
Completion: Jul 1, 2025
NCT06715085
PRGF-ENDORET® Infiltrations in the Treatment of Low Back Pain.
Start: Jan 23, 2025
Completion: Feb 1, 2027
NCT07146412
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
Start: May 2, 2025
Completion: Apr 30, 2026
NCT06952998
Efficacy of Plasma Rich in Growth Factors (PRGF) in the Treatment of Foot Ulcers in Diabetic Patients With Peripheral Arterial Disease
Start: Nov 1, 2025
Completion: May 30, 2027
Loading map...